0 citations
OP 1.8 – 00204 Romidepsin in combination with the BCL-2 antagonist venetoclax synergistically reduce the size of the HIV reservoir
Journal of Virus Eradication2022Vol. 8, pp. 100103–100103
Citations Over Time
Y. Kim, C. Tumpach, Jesslyn Ong, A. Solomon, J. McMahon, P. Arandjelovic, M. Pelligrini, M. Roche, S. Lewin
Related Papers
- → The discovery and development of romidepsin for the treatment of T-cell lymphoma(2017)74 cited
- → Use of class I histone deacetylase inhibitor romidepsin in combination regimens(2016)40 cited
- → Potential of BCL2 as a target for chronic lymphocytic leukemia treatment(2018)18 cited
- Clinical development of histone deacetylase inhibitor romidepsin.(2010)
- Romidepsin:a new therapy for cutaneous T-cell lymphoma(2011)